Sana CEO reveals details about stealthy gene therapy startup that has raised more than $700M
Luke Timmerman interviews Sana Biotechnology CEO Steve Harr at the GeekWire Summit this week. Sana Biotechnology CEOSteve Harr
More boards from User764112
Notice label will go here